Journal for ImmunoTherapy of Cancer (Nov 2023)
636 BASECAMP-1: A master prescreening study to identify patients with high-risk or metastatic solid tumors with HLA loss of heterozygosity (LOH) in preparation for Tmod CAR T-cell therapy trials
- Marcela Maus,
- Caron Jacobson,
- Frederick L Locke,
- Oliver Dorigo,
- David Maloney,
- Jennifer Specht,
- Saurabh Dahiya,
- Edward Garon,
- Diane M Simeone,
- John Welch,
- Kedar Kirtane,
- Marwan Fakih,
- Julian Molina,
- Ariane Lozac’hmeur,
- J Randolph Hecht,
- Jong Chul Park,
- Caleb Smith,
- Theodore Welling,
- M Pia Morelli,
- Patrick M Grierson,
- Tomislav Dragovich,
- William Y Go,
- Eric W Ng,
- Peter Vu,
- Jessica Tebbets,
- Gayanie Ong
Affiliations
- Marcela Maus
- 11Massachusetts General Hospital, Boston, MA, USA
- Caron Jacobson
- Aff216 grid.65499.370000000121069910Dana-Farber Cancer Institute Boston MA USA
- Frederick L Locke
- Department of Blood & Marrow Transplant and Cellular Immunotherapy, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
- Oliver Dorigo
- Aff2 grid.168010.e0000000419368956Stanford Women’s Cancer Center, Division of Gynecologic Oncology, Department of Obstetrics and GynecologyStanford University School of Medicine 94305 Stanford CA USA
- David Maloney
- Critical Care Medicine, Children`s Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
- Jennifer Specht
- 2Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- Saurabh Dahiya
- Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland - Baltimore, University of Maryland School of Medicine, Baltimore, Maryland, USA
- Edward Garon
- David Geffen School of Medicine, UCLA, University of California Los Angeles, Los Angeles, California, USA
- Diane M Simeone
- 1Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA
- John Welch
- 15A2 Biotherapeutics, Inc., Agoura Hills, CA, USA
- Kedar Kirtane
- 10 H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
- Marwan Fakih
- 6 Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center Duarte, Duarte, California, USA
- Julian Molina
- Mayo Clinic, Rochester, MN, USA
- Ariane Lozac’hmeur
- 3Tempus, Chicago, IL, USA
- J Randolph Hecht
- 9David Geffen School of Medicine at UCLA, Los Angeles, USA
- Jong Chul Park
- 2Harvard Medical School, Boston, MA, USA
- Caleb Smith
- Mayo Clinic, Rochester, MN, USA
- Theodore Welling
- 1New York University Langone Health, New York, NY, USA
- M Pia Morelli
- 4The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Patrick M Grierson
- 7Washington University in St. Louis, Saint Louis, MO, USA
- Tomislav Dragovich
- 15Banner MD Anderson Cancer Center, Gilbert, AZ, USA
- William Y Go
- 16A2 Biotherapeutics, Inc., Agoura Hills, CA, USA
- Eric W Ng
- 16A2 Biotherapeutics, Inc., Agoura Hills, CA, USA
- Peter Vu
- 8University of California San Diego Health, San Diego, CA, USA
- Jessica Tebbets
- 15A2 Biotherapeutics, Inc., Agoura Hills, CA, USA
- Gayanie Ong
- 15A2 Biotherapeutics, Inc., Agoura Hills, CA, USA
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.0636
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.